Yongsu Choi
Sungkyunkwan University · Medicine
About the Lab
Professor Yongsu Choi's research lab focuses on regenerative medicine and cellular therapy, with a central emphasis on mitochondrial transfer as a novel therapeutic strategy for diseases involving mitochondrial dysfunction. The lab investigates mitochondrial transplantation in various pathological contexts, including tendinopathy and degenerative diseases like diabetes, aiming to restore cellular function through exogenous mitochondria. They also explore stem cell and dendritic cell interactions to modulate immune tolerance, highlighting translational applications in tissue repair and immune regulation. Their work combines innovative cell delivery techniques—such as centrifugation-based mitochondrial transfer—with in vitro and in vivo models to advance regenerative therapies.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
15Abstract Mitochondria are essential organelles involved in the maintenance of cell growth and function, and have been investigated as therapeutic targets in various diseases. Recent studies have demonstrated that direct mitochondrial transfer can restore cellular functions of cells with inherited or acquired mitochondrial dysfunction. However, previous mitochondrial transfer methods are inefficient and time-consuming. Here, we developed a simple and easy mitochondrial transfer protocol using cen
Tendinopathy is a common musculoskeletal condition causing pain and dysfunction. Conventional treatment and surgical procedures for tendinopathy are insufficient; accordingly, recent research has focused on tendon-healing regenerative approaches. Tendon injuries usually occur in the hypoxic critical zone, characterized by increased oxidative stress and mitochondrial dysfunction; thus, exogenous intact mitochondria may be therapeutic. We aimed to assess whether mitochondrial transplantation could
OBJECTIVES: Although the standard video-assisted thoracoscopic surgery (VATS) approach is generally performed through two to four incisions, uniportal VATS pulmonary resection has recently been reported to be a promising, less invasive alternative. To evaluate the adequacy of uniportal VATS lobectomy as an alternative to conventional VATS lobectomy in lung cancer, we analysed and compared the outcomes of uniportal and conventional VATS lobectomies. METHODS: Retrospective observational data for p
Hypocotyl segments of Eleutherococcus senticosus cultured on Murashige and Skoog's (MS) medium with 4.5 μ m 2,4-D produced somatic embryos directly from the surface of explants without intervening callus formation. When these somatic embryos were subcultured to the same MS medium with 4.5 μ m 2,4-D, friable embryogenic calli were formed mainly from radicle tips of somatic embryos, but at a low frequency (5%). Selected embryogenic calli were maintained on MS agar or liquid medium with 4.5 μ m 2,4
Strategies designed to produce functional cells from stem cells or from mature cells hold great promise for treatment of different cell-degenerative diseases. Type 1 and type 2 diabetes are examples of such diseases. Although different in origin, both involve inadequate cell mass of insulin-producing beta cells, the most abundant cell type of pancreatic islets of Langerhans. Practical realization of such strategies is highly dependent on the elucidation of physiological mechanisms responsible fo
Immature dendritic cells (imDCs) are increasingly viewed as mediators of T-cell tolerance. We investigated factors enabling induction of regulatory T (Treg) cells through syngeneic imDC/mesenchymal stem cell (MSC) co-cultures in vitro and immunosuppressive effects of MSC-mediated imDCs (MSCs were excluded after 72 h co-culture) in vivo. In these experiments, we found that Foxp3(+) Treg cell population remarkably increased after the T cell priming phase when splenocytes were co-cultured with both
In this study, we developed a composite filler comprising cross-linked hyaluronic acid (HA) and human collagen (COL) derived from the human umbilical cord with the aim of improving its biocompatibility and longevity compared with commercially available fillers. After HA/ COL composite fillers were made in two different ratios (10:1 and 5:1), the physical properties of the fillers were evaluated. The interior morphologies and in vivo weight change of these hydrogels were also characterized at 1-1
BACKGROUND: Sepsis has a high mortality rate, but no specific drug has been proven effective, prompting the development of new drugs. Immunologically, sepsis can involve hyperinflammation, immune paralysis, or both, which might pose challenges during drug development. Recently, mitochondrial transplantation has emerged as a treatment modality for various diseases involving mitochondrial dysfunction, but it has never been tested for sepsis. METHODS: We isolated mitochondria from L6 muscle cells a
Research Areas
Dive deeper into Yongsu Choi's research on Nubint
Open this lab's papers in the app to read with AI, summarize, and cite in your writing.